Solara Active Pharma Sciences Ltd. Reports Strong Revenue Growth in December Quarter

Solara Active Pharma Sciences Ltd. has announced a remarkable turnaround in its financial performance for the December quarter, achieving consolidated revenues of ₹3 billion from operations. This significant increase highlights the company's recovery, with a profit of ₹45 lakh compared to a net loss of ₹139.87 crore during the same period last year. Management attributes this success to improved operational efficiency and a growing order book, positioning Solara for continued growth in the pharmaceutical sector. 

 

Source: Moneycontrol, CNBC TV18